5/18. Ibalizumab- (March 2018)
Drug Name:
5/18. Ibalizumab- (March 2018)
List Of Brands:
Indication Type Description:
Indication:
U.S. FDA APPROVED DRUGS DURING 2018
Sr.No- 5
Name of the Drug- TROGARZO
Active Ingredient - Ibalizumab-ulyk
Pharmacological Classification-
To treat HIV patients who have limited treatment options
Date of Approval- 3-066-2018
(Ref- FDA approved List 2018)